WallSt Focus
Total 822 Posts
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share, valuing the deal at approximately $412 million.
July CPI Breakdown: Inflation Shows Signs of Pressure, but Fed Rate Cut Likely
The latest Consumer Price Index (CPI) report for July has painted a mixed picture for inflation, with consumer prices rising, but not at the rate many economists had feared.
Palantir’s Pentagon Power Play: The Story Behind The $7.1 Billion Backlog & The 600% Rally!
As Palantir’s stock has climbed over 600% in the past year, its LTM EV/ Revenue multiple stands at 118x which demands scrutiny against concentration risks, ethical controversies, and mounting regulatory overhang.
Stock Market Today: Stocks Rise as CPI Data and Trump Nominee Fuel Market Optimism
US stocks edged higher on Tuesday, driven by fresh inflation data and President Trump's announcement of his nominee for the Bureau of Labor Statistics.
Stock Market Today: Stock Market Wavers as Tariff Talks and Inflation Data Loom
US stocks were mixed on Monday, as President Trump’s announcement about a 90-day extension on China tariffs sent ripples through the market.
Gold Surges Amid Tariff Uncertainty and Market Reactions
Gold futures experienced a massive surge on Friday, with the precious metal hitting record highs on the heels of tariff confusion surrounding Swiss gold imports.
Stock Market Today: Stocks Surge Amid Tariff Moves and Fed Speculation
U.S. stocks bounced back on Friday as investors digested news regarding President Trump’s sweeping tariff policies and his nomination of Stephen Miran to the Federal Reserve Board of Governors.